Search

Researchers are looking for ways to make cancer cells more visible to the immune system.

… Wednesday, September 19, 2018 Summary Researchers are looking for ways to make checkpoint inhibitor drugs more effective. One tactic is by making cancer cells more visible to the immune system. Drugs called immune checkpoint inhibitors have made a significant difference for some people with cancer. They

A renowned chemist with 25 years of industry and academic experience, Michael Foley will lead a pioneering collaboration designed to speed the development of new drugs for people with cancer and other diseases.

… Thursday, December 5, 2013 Summary A renowned chemist with 25 years of industry and academic experience, Michael Foley will lead a pioneering collaboration designed to speed the development of new drugs for people with cancer and other diseases. Michael A. Foley, a renowned chemist and entrepreneur,

Learn about ashwagandha, an herb used for stress relief.

… Tuesday, February 1, 2022 Ashwagandha ( Withania somnifera ) is an herb that has been used in Ayurveda, the traditional Indian medical system, for more than 3,000 years. It is an adaptogen, which means it is believed to strengthen the body against physical or biological stress. Ashwagandha is used to

Memorial Sloan Kettering, one of the nation’s top cancer treatment and research institutions, is expanding its reach on Long Island with a new 114,000-square-foot freestanding cancer treatment center in Nassau County. Once complete, MSK Nassau will house the area’s most comprehensive cancer care program, centrally located and staffed by the most forward-thinking and compassionate healthcare teams whose sole focus is caring for people with cancer.

… Thursday, October 19, 2017 Memorial Sloan Kettering, one of the nation’s top cancer treatment and research institutions, is expanding its reach on Long Island with a new 114,000-square-foot freestanding cancer treatment center in Nassau County. Once complete, MSK Nassau will house the area’s most comprehensive

A simple blood test performed at age 60 can determine a man's risk of dying from prostate cancer within the next 25 years, according to a new study led by Memorial Sloan Kettering Cancer Center investigators. The study's findings suggest that regular prostate-specific antigen (PSA) screening for prostate cancer should be focused on men who receive high readings from a PSA test performed at age 60 and that men with low readings can be spared further screening.

… Wednesday, September 1, 2010 A simple blood test performed at age 60 can determine a man’s risk of dying from prostate cancer within the next 25 years, according to a new study led by Memorial Sloan Kettering Cancer Center investigators. The study’s findings suggest that regular prostate-specific antigen

Learn why surgery remains a very effective treatment for most prostate cancers.

… Wednesday, June 13, 2018 Summary Surgery can cure prostate cancer if the disease hasn’t spread outside of the prostate gland. The most common procedure is a radical prostatectomy . It can be done as traditional open surgery or in a minimally invasive approach , including robot-assisted laparoscopic surgery

As a tribute to Memorial Sloan Kettering Board member Josephine “Josie” Robertson, Memorial Sloan Kettering has joined with The Robertson Foundation to undertake two high-profile initiatives — the Josie Robertson Surgery Center and the Josie Robertson Investigators Program — made possible by a $50 million commitment from The Robertson Foundation.

… Wednesday, December 21, 2011 As an enduring tribute to a valued Board member and woman of incomparable grace, Memorial Sloan Kettering Cancer Center has joined with The Robertson Foundation to undertake two high-profile initiatives in honor of Josephine “Josie” Robertson: the Josie Robertson Surgery

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery during the American Association for Cancer Research (AACR) Annual Meeting on April 5-10 in San Diego, California.

… Monday, April 1, 2024 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer discovery during the American Association for Cancer Research (AACR) Annual Meeting

Investigators have employed mutant mice to study how the accumulation of genetic errors is managed during egg and sperm formation.

… Wednesday, November 17, 2021 Sometimes the best way to understand a biological process is to disrupt the normal process and analyze the result. That’s why Sloan Kettering Institute (SKI) researchers used a strain of mutant mice as a means to uncover new clues about the process of meiosis, which forms

Ingo K. Mellinghoff, MD, FACP, neuro-oncologist and Chair of the Department of Neurology, presented significant results from a phase III trial in patients with residual or recurrent grade 2 glioma with an IDH1/2 mutation.

… Sunday, June 4, 2023 Breakthrough data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting press program and simultaneously published in  The New England Journal of Medicine (NEJM)  today found that vorasidenib